What is the market doing?
What the tape says about TXG
10x Genomics, Inc. is +402% over the past year while the S&P 500 is +23%: 380 points ahead of the market.
+402%
1-year return · S&P 500 +23%
- vs 200-day average
- +151%
vs 200-day average · a clear uptrend
- RSI (14)
- 79
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −1.2%
Below its 52-week high
Details›
- Last close2026-08-26
- $64.30
- 1 monthS&P 500 +3.7%
- +34%
- 1 yearS&P 500 +23%
- +402%
- 5 yearsS&P 500 +87%
- −64%
- vs 50-day average$44.28
- +45%
- 52-week high
- $65.11
- 52-week low
- $11.34
- Annualised volatility
- 74%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$1.1M
| Year | Return |
|---|---|
| 2026 (year to date) | +294% |
| 2025 | +14% |
| 2024 | −74% |
| 2023 | +54% |
| 2022 | −76% |
| 2021 | +5.2% |
| 2020 | +86% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 5 of 7 | +5.2% |
| Feb | 7 | 4 of 7 | −3.6% |
| Mar | 7 | 2 of 7 | −7.9% |
| Apr | 7 | 3 of 7 | −4.2% |
| May | 7 | 4 of 7 | +2.3% |
| Jun | 7 | 5 of 7 | +7.5% |
| Jul | 7 | 5 of 7 | +8.5% |
| Aug | 7 | 4 of 7 | +4.4% |
| Sep | 6 | 1 of 6 | −10% |
| Oct | 7 | 4 of 7 | +0.61% |
| Nov | 7 | 5 of 7 | +17% |
| Dec | 7 | 2 of 7 | +1.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Health Information Services
Ranks #2 of 14 by Smart Score